Moleculin Biotech, Inc.

MBRX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 17 employees
495
SEC Filings
$2.73
Close 2026-05-27
17
Employees

Business Summary

BUSINESS Business Summary We are a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin, which we believe is anext-generation anthracycline and, with it, are conducting a pivotal Phase 3 trial in combination with cytarabine for the treatment of subjects with relapsed/refractory (R/R) acute myeloid leukemia (AML). We call this the MIRACLE trial (derived from Moleculin R/R AML AnnAraC Clinical Evaluation).A bli...

Latest Stock Quote

MBRX 2026-05-27 $2.73 O:$2.48 H:$2.79 L:$2.411 Vol:0.5M VWAP:$2.6538
origin leaf: 43dfe80fbd38209ad2b1f9ea2912edd14f4d1a33bb4506315213175c481af915

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-182025-12-310001437749-26-008841EDGAR92K words
2025-03-212024-12-310001437749-25-008751EDGAR—
2024-03-222023-12-310001437749-24-009044EDGAR—
2023-03-222022-12-310001437749-23-007537EDGAR—
2022-03-242021-12-310001437749-22-007103EDGAR—
2021-03-242020-12-310001437749-21-006940EDGAR—
2020-03-192019-12-310001659617-20-000066EDGAR—
2019-02-212018-12-310001659617-19-000018EDGAR—
2018-03-282017-12-310001659617-18-000027EDGAR—
2017-04-032016-12-310001144204-17-018352EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001437749-25-034839EDGAR27K words
2025-08-122025-06-300001437749-25-026225EDGAR—
2025-05-132025-03-310001437749-25-016466EDGAR—
2024-11-082024-09-300001437749-24-034236EDGAR—
2024-08-132024-06-300001437749-24-026367EDGAR—
2024-05-102024-03-310001437749-24-016031EDGAR—
2023-11-132023-09-300001437749-23-031391EDGAR—
2023-08-102023-06-300001437749-23-023021EDGAR—
2023-05-102023-03-310001437749-23-013582EDGAR—
2022-11-102022-09-300001437749-22-026888EDGAR—
2022-08-122022-06-300001437749-22-020389EDGAR—
2022-05-112022-03-310001437749-22-011925EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-230001437749-26-009298EDGAR1K words
2026-03-190001437749-26-008951EDGAR—
2026-03-190001437749-26-008949EDGAR—
2026-02-200001437749-26-004800EDGAR—
2026-02-180001437749-26-004558EDGAR—
2026-02-180001437749-26-004455EDGAR—
2026-02-170001437749-26-004236EDGAR—
2026-02-050001437749-26-003119EDGAR—
2026-01-200001437749-26-001484EDGAR—
2026-01-130001437749-26-001140EDGAR—

495 total filings indexed. 463 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001659617
TickerMBRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.moleculin.com
Listed2016-06-02

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d1f4f30b7839b8cdc4ca5a5fd8b60745fbcda533b0112cc078e200f750ac4a5b
parent: a8db1738e9ab3286db415088717f2ed71c25fa91a8d4418a94e2903cef4aecee
content hash: ab328511a208d38639846b5a403c387bd05ab1b91d0ff1ae80ec51904fb271f1
signed: 2026-06-02T19:01:49.910Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf